Introduction to Hangzhou Richerpharm Technology Co., Limited
At the forefront of China's pharmaceutical innovation stands Hangzhou Richerpharm Technology Co., Limited. As a high-tech enterprise dedicated to the R&D, production, and sales of advanced pharmaceutical intermediates, APIs, and custom synthesis services, Richerpharm has carved a niche for itself in the global market. The company's foundation is built upon a profound commitment to scientific excellence and stringent quality control, ensuring that every product meets the highest international standards. With a state-of-the-art manufacturing facility and a team of seasoned experts, Richerpharm specializes in providing high-purity, reliable products for various therapeutic areas. Their customer-centric approach, combined with a robust R&D pipeline, makes them a dynamic and trusted partner for pharmaceutical companies worldwide seeking innovative and efficient synthesis solutions.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Hisun is a pharmaceutical powerhouse with a significant global footprint in APIs. It offers an extensive portfolio of anti-infectives, cardiovascular drugs, and oncology APIs. The company operates in full compliance with international GMP standards, supplying to regulated markets like the US, EU, and Japan. Hisun's strong R&D focus and vertically integrated production capabilities make it a reliable and strategic partner for global pharmaceutical
companies.
North China Pharmaceutical Co., Ltd. (NCPC)
As one of China's largest and oldest antibiotic manufacturers, NCPC has a formidable reputation. It produces a wide range of antibiotics, vitamins, and biotech products. With decades of experience, NCPC boasts advanced fermentation technology and a comprehensive product line, serving essential needs in the global pharmaceutical supply chain with a focus on quality and scale.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Fosun Pharma is a global healthcare group with a strong API manufacturing arm. It has a diversified API product portfolio and has expanded its international presence through strategic acquisitions. The company emphasizes innovation and operates multiple GMP-certified plants, supplying high-quality intermediates and APIs worldwide while integrating its pharmaceutical value chain.
Cisen Pharmaceutical Co., Ltd.
Specializing in large-volume parenteral (LVP) products and APIs, Cisen is a key player in the Chinese pharmaceutical landscape. The company has a robust portfolio that includes APIs for electrolytes, nutritionals, and anti-infectives. Its modern production facilities and strict quality management system ensure the consistent delivery of safe and effective pharmaceutical ingredients.
Zhejiang Medicine Co., Ltd. (ZMC)
ZMC is renowned for its production of high-quality vitamins, APIs, and formulations. It is a leading global supplier of natural Vitamin E and other fine chemicals. The company's commitment to technological advancement and stringent quality control has cemented its position as a trusted supplier in both the pharmaceutical and nutraceutical industries.
Luye Pharma Group Ltd.
Luye Pharma is an international pharmaceutical company with a growing API business segment. It focuses on developing and manufacturing APIs for its proprietary products in oncology and CNS areas, while also providing contract manufacturing services. Their modern production bases adhere to international GMP standards, supporting global clinical and commercial supply.
Sichuan Kelun Pharmaceutical Co., Ltd.
Kelun is a leading Chinese pharmaceutical company, particularly strong in infusion therapy and antibiotics. Its API division produces a wide array of substances, including non-penicillin antibiotics and specialty chemicals. With a focus on R&D and compliance, Kelun supplies APIs to its own formulation business and to partners worldwide.
Jiangsu Hengrui Medicine Co., Ltd.
Hengrui is a leading force in China's innovative drug R&D. While famous for its proprietary branded formulations, it also possesses strong capabilities in manufacturing the corresponding high-potency APIs, especially in oncology and surgical anesthesia. Their API production is characterized by high purity and advanced synthesis technology.
Tianjin Pharmaceutical Group Co., Ltd.
This state-owned enterprise is a major comprehensive pharmaceutical group in North China. It has a long history and a broad product range covering APIs for vitamins, hormones, and antibiotics. The group maintains a solid manufacturing base and continues to be a significant contributor to China's API export market.